6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01370811 (ClinicalTrials.gov)	August 2011	8/6/2011	A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson' ...	A Phase II, Double-blind, Randomized, Placebo-controlled 4-way Crossover Study to Evaluate the Relat ...	Sialorrhoea	Drug: OC oral solution treatment A;Drug: OC oral solution treatment B;Drug: OC oral solution treatme ...	Orient Pharma Co., Ltd.	NULL	Completed	40 Years	80 Years	Both	24	Phase 2	United States
2	NCT00892450 (ClinicalTrials.gov)	May 2009	28/4/2009	Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease	Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease: A Randomized, Double-blind, C ...	Parkinson's Disease;Overactive Bladder	Drug: Oxybutynin and darifenacin	Department of Veterans Affairs	NULL	Completed	N/A	N/A	Both	12	N/A	United States
3	EUCTR2007-004654-81-GB (EUCTR)	20/12/2007	16/10/2007	A phase IIa study to evaluate the relative efficacy and safety/tolerability of a single agent vs. a ...	A phase IIa study to evaluate the relative efficacy and safety/tolerability of a single agent vs. a ...	Sialorrhoea associated with Parkinson's Disease MedDRA version: 9.1;Level: LLT;Classification code 1 ...	Trade Name: Catapres ampoules INN or Proposed INN: Clonidine hydrochloride Trade Name: Ditropan elixir I ...	Summit (Cambridge) Ltd.	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	United Kingdom

First Previous1Next Last